weekly_bull3

The Week in Review: July 28, 2017 – August 4, 2017

Friday, August-4-17

News Recap

The US FDA has approved AbbVie’s Mavyret and granted expanded access to Epclusa for HIV-HCV coinfection. In Canada, all prisoners with HCV in federal prisons will be treated! New disease burden estimates for BC have been released, and a miniseries about the tainted blood scandal in Canada is in the works!

Read more…http://hepcbc.ca/2017/08/04/week-review-july-28-august-4-2017/

red line

The Week in Review: July 21, 2017 – July 28, 2017

Friday, July-28-17

News Recap

WHD photos from Victoria BC, inspiring message from Daryl Luster, HBV in men, liver transplants and cardiovascular disease, chronic HEV, DIALIVE liver dialysis machine, how plums may help treat HCV… and more…

Read more…http://hepcbc.ca/2017/07/28/week-review-july-21-july-28-2017/

red line

The Week in Review: July 14, 2017 – July 21, 2017

Friday, July-21-17

News Recap

Vosevi approved in USA; Call for input for Canadian approval of Vosevi; Know Your Status – Know Your Status – Know Your Status!!! Mouse model for vaccine, engineered liver tissue scaffold, liver cancer treatment, disease progression post-cure… and more…

Read more…http://hepcbc.ca/2017/07/21/week-review-july-14-july-21-2017/

red line

The Week in Review: July 7, 2017 – July 14, 2017

Friday, July-14-17

News Recap

Rapid access clinics in Victoria, support in Comox, price gouging in Norway, hepatitis E caused by pork, new clinical trial for HBV and another look at the tainted blood scandal in the UK

Read more…http://hepcbc.ca/2017/07/14/week-review-july-7-july-14-2017/

red line

 

2017

June Archive:

May Archive:

April Archive:

March Archive:

February Archive:

January Archive:

 

2016

December Archive:

November Archive:

October Archive:

September Archive: